CardioNet, Inc is one of the leading wireless medical technology companies that focuses on the diagnosis and monitoring of cardiac arrhythmias. The company recently announced that the Centers for Medicare and Medicaid Services, established a national rate in The Medicare Program Final Rule for the technical component of mobile cardiovascular telemetry.

According to the information currently available, the company expects a price of approximately $800 for their geographical area to become effective as of January 1, 2011. This new price, will replace the carrier price of $754 previously implemented by Highmark Medicare Services.

In a press release, Joseph Capper, president and chief executive officer of CardioNet, said, "We are pleased that our ongoing dialogue with CMS over the last two years culminated in a national price. We believe that this sends a clear message that MCOT is an established, accepted technology that is critical to providing better patient care to Medicare beneficiaries nationwide."

On Nov. 8, at 5:00 PM EDT, the company will release more information on CMS' decision to establish a national rate on its investor conference call to discuss the company's operating results for the third quarter of 2010.

CardioNet is one of the leading providers of ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health. CardioNet's initial efforts are focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders, with a solution that it markets as Mobile Cardiac Outpatient Telemetry.